CD4+ T-cells from peripheral blood of a patient with psoriasis recognize keratin 14 peptide but not 'homologous' streptococcal M-protein epitope

Journal of Dermatological Science

Volumn 30, Issue 3, 2002, Pages 240-247

  Kobayashi, Hiroya ^a   Takahashi, Michinari ^a   Takahashi, Hidetoshi ^a   Ishida Yamamoto, Akemi ^a   Hashimoto, Yoshio ^a   Sato, Keisuke ^a   Tateno, Masatoshi ^a   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Keratin; Peptide; T cell

Indexed keywords

ASPARTYLLEUCYLARGINYLASPARAGINYLLYSYLISOLEUCYLLEUCYLTHREONYLALANYLTHREONINE; CD4 ANTIGEN; CROSS REACTING ANTIBODY; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA A26 ANTIGEN; HLA ANTIGEN; HLA B16 ANTIGEN; HLA B27 ANTIGEN; HLA DO8 ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DR8 ANTIGEN; INTERLEUKIN 4; KERATIN; M PROTEIN; PEPTIDE; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; CARRIER PROTEIN; CYTOKERATIN 14; KRT14 PROTEIN, HUMAN; OUTER MEMBRANE PROTEIN; PEPTIDE FRAGMENT; STREPTOCOCCAL M PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IRRADIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; PSORIASIS; SEQUENCE HOMOLOGY; SKIN INFLAMMATION; STREPTOCOCCUS GROUP A; T LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CELL LINE; IMMUNOLOGY;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPES; HUMANS; KERATIN-14; KERATINS; PEPTIDE FRAGMENTS; PSORIASIS;

EID: 0036890496     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00111-1     Document Type: Article

References (27)

1. Nickoloff B.J. The immunologic and genetic basis of psoriasis. Arch. Dermatol. 135:1999;1104-1110.
2. Bos J.D., Hulsebosch H.J., Krieg S.R., Bakker P.M., Cormane R.H. Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonalantibodies. Arch. Dermatol. Res. 275:1983;181-189.
3. Baker B.S., Swain A.F., Fry L., Valdimarsson H. Epidermal T lymphocytes an HLA-DR expression in psoriasis. Br. J. Dermatol. 110:1984;555-564.
4. Prinz J.C., Gross B., Vollmer S., Trommler P., Strobel I., Meurer M., Plewig G. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur. J. Immunol. 24:1994;593-598.
5. Vollmer S., Menssen A., Trommler P., Schendel D., Prinz J.C. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:1994;2377-2382.
6. Griffiths C.E., Powles A.V., Leonard J.N., Fry L., Baker B.S., Valdimarsson H. Clearance of psoriasis with low dose cyclosporin. Br. Med. J. (Clin. Res. Ed.). 293:1986;731-732.
7. The European FK506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind placebo-controlled study. Arch. Dermatol. 132:1996;419-423.
8. Telfer N.R., Chalmers R.J., Whale K., Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch. Dermatol. 128:1992;39-42.
9. Manjula B.N., Trus B.L., Fischetti V.A. Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc. Natl. Acad. Sci. USA. 82:1985;1064-1068.
10. McFadden J., Valdimarsson H., Fry L. Cross-reactivity between streptococcal M surface antigen and human skin. Br. J. Dermatol. 125:1991;443-447.
11. Pruksakorn S., Currie B., Brandt E., Phornphutkul C., Hunsakunachai S., Manmontri A., Robinson J.H., Kehoe M.A., Galbraith A., Good M.F. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int. Immunol. 6:1994;1235-1244.
12. Valdimarsson H., Baker B.S., Jonsdottir I., Powles A., Fry L. Psoriaisi: a T-cell- mediated autoimmune disease induced by streptococcal superantigens. Immunol. Today. 16:1995;145-149.
13. Sigmundsdottir H., Sigurgeirsson B., Troye-Blomberg M., Good M.F., Valdimarsson H., Jonsdottir I. Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins. Scand. J. Immunol. 45:1997;688-697.
14. Valdimarsson H., Sigmundsdottir H., Jonsdottir I. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin. Clin. Exp. Immunol. 107:1997;21-24.
15. McGuire J., Osber M., Lightfoot L. Two keratins MW 50 000 and 56 000 are synthesized by psoriatic epidermis. Br. J. Dermatol. 111:1984;27-37.
16. Leigh I.M., Navsaria H., Purkis P.E., McKay I.A., Bowden P.E., Riddle P.N. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br. J. Dermatol. 133:1995;501-511.
17. + T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase. Cancer Res. 58:1998;296-301.
18. Baker B.S., Powles A.V., Valdimarsson H., Fry L. An altered response by psoriatic keratinocytes to gamma interferon. Scand. J. Immunol. 28:1988;735-740.
19. Scheynius A., Fransson J., Johansson C., Hammar H., Baker B., Fry L. Valdimarsson expression of interferon-gamma receptors in normal and psoriatic skin. J. Invest. Dermatol. 98:1992;255-258.
20. Baadsgaard O., Fisher G., Voorhees J.J., Cooper K.D. The role of the immune system in the pathogenesis of psoriasis. J. Invest. Dermatol. 95:1990;32-34.
21. de Bueger M., Bakker A., Goulmy E. Human keratinocytes activate primed major and minor histocompatibility antigen specific Th cells in vitro. Transplant Immunol. 1:1993;52-59.
22. Viac J., Gueniche A., Gatto H., Lizard G., Schmitt D. Interleukin-4 and interferon-gamma interactions in the induction of intercellular adhesion molecule-1 and major histocompatibility complex class II antigen expression of normal human keratinocytes. Exp. Dermatol. 3:1994;72-77.
23. Albanesi C., Cavani A., Girolomoni G. Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J. Invest. Dermatol. 110:1998;138-142.
24. Swerlick R.A., Cunningham M.W., Hall N.K. Monoclonal antibodies cross-reactive with group A streptococci and normal and psoriatic human skin. J. Invest. Dermatol. 87:1986;367-371.
25. Aoki S., Yaoita H., Kitajima Y. An elevated level of autoantibodies against 48- to 50-kDa keratins in the serum of patients with psoriasis. J. Invest. Dermatol. 92:1989;179-183.
26. Henderson C.A., Highet A.S. Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections. Br. J. Dermatol. 118:1988;559-561.
27. Chicz R.M., Urban R.G., Gorga J.C., Vignali D.A., Lane W.S., Strominger J.L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:1993;27-47.